Gilead advances Covid-born oncology campaign with patient and advocate stories
Chaunté Lowe is a four-time Olympic high jump competitor, and she’s also Gilead Sciences’ newest patient advocate around triple negative breast cancer (TNBC). She is a “TNBC survivor and thriver” speaking out as part of Gilead Oncology’s broader “Means to Me” oncology campaign that matches science and the cancer community.
The social media campaign initially began in 2021 during the Covid pandemic via Zoom shoots with patients, advocates, healthcare providers and Gilead employees, meant to showcase their different views about the real effects of industry science and research. The casual style on social media continues purposefully today as a simple way for people to participate, but also to reflect the more laid back style of the social channels. The campaign is running on Twitter, Facebook and LinkedIn.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
